Supplementation of omega-3 fatty acids with anti-cancer drugs may improve the treatment response and quality of life (QOL) in cancer patents, according to a study published in the Journal of Parenteral and Enteral Nutrition.
The study was conducted by the University hospitals of Leicester in Britain. The study investigated 50 patients with advanced pancreatic cancer. The study subjects were assigned to receive 1000 mg of Omega-3 fatty acids weekly followed by 100 g of omega-3 rich lipid emulsion for three weeks, followed by a week rest.
Upon examining the treatment activity in response and disease stabilization rates, clinically significant reduction in liver metastasis volume, physical activity and improved quality of life scores were observed in the group of patients.
This is the first study to report the benefits of omega-3 fatty acids use with chemotherapy in a cancer clinic setting. The results warranted additional studies including a large-scale, randomized phase III trial.
Find us on facebook